Tuesday, October 13, 2009


Many will take issue with our running commentary and review of the published evidence on hyperbaric oxygen therapy for the treatment of multiple sclerosis. In the UK, certainly, they'd be right to say there's nothing scant about the widespread practice and apparent benefits of HBOT for MS. For 25 years the Multiple Sclerosis National Therapy Centres have provided over 2 million HBOT sessions to 13,000 members through a network of 36 charitable clinics. The organization seems to us a model of patient power at work. And what a fine platform it would make for the multicenter clinical trial or landmark observational research the medical literature is sorely missing.

No comments:

Post a Comment